Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard Malcolmson
Richard Malcolmson
Novartis
Amorphous solid
Particle
Chemistry
Tobramycin Sulfate
Glass transition
4
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Novel Toxicology Program to Support the Development of Inhaled VentaProst
2020
International Journal of Toxicology
Jeffrey S. Tepper
Juergen W. Pfeiffer
Kim Bujold
James B. Fink
Richard Malcolmson
Dennis Sullivan
Simon Authier
Plamena Entcheva-Dimitrov
Andrew P.-Z. Clark
Show All
Source
Cite
Save
Citations (1)
Physical characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation
2017
Molecular Pharmaceutics
Danforth P. Miller
Trixie Tan
John Nakamura
Richard Malcolmson
Thomas E. Tarara
Jeffry G. Weers
Show All
Source
Cite
Save
Citations (12)
Inhalation of tobramycin using simulated cystic fibrosis patient profiles
2016
Pediatric Pulmonology
Alfred Haynes
David E. Geller
Jeffry G. Weers
Brian Ament
Richard Pavkov
Richard Malcolmson
Laurie Debonnett
Paul Mastoridis
Anthony Yadao
Silvia Heuerding
Show All
Source
Cite
Save
Citations (17)
Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
2015
Molecular Pharmaceutics
Danforth P. Miller
Trixie Tan
Thomas E. Tarara
John Nakamura
Richard Malcolmson
Jeffry G. Weers
Show All
Source
Cite
Save
Citations (25)
1
map